Clinical Trial Update: Compound Edaravone Injection for Acute Ischemic Stroke [Phase 2]

View source ↗

Summary

Phase 2 trial of Edaravone Injection for acute ischemic stroke has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Edaravone (Edaravone)

Snippet

Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. | Conditions: Acute Ischemic Stroke | Phase 2 | Status: COMPLETED